Building on established “Collect and Review” Solutions, UFED Ultra brings new level of excellence to digital forensics

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced the appointment of Jared Kelly as Senior Vice President, General Counsel and Corporate Secretary. After...

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and...

TEL AVIV, Israel, June 05, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT), a leading global renewable energy platform, has entered into a corporate power purchase agreement (“PPA”) with...

-Among findings: digital natives are changing buying behaviors; ‘consumerization’ of B2B is accelerating; analytics and data utilization improve; AI will have a growing impact on thought leadership, content & creative...

In a preclinical model of ischemic stroke, systemic delivery of a selective Fzd4 Wnt antibody strongly reduced blood-brain-barrier leakage, death of surrounding brain tissue, tissue swelling, while improving neurologic...

IRVINE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

Additional presentations highlight new findings on xenotransplantation graft rejection, providing potential methods to predict and improve future clinical outcomes

BOULDER, Colo., June 05, 2023 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) (“Gaia” and/or the “Company”), a conscious media and community company, announced that CFO Paul Tarell will participate in the Water Tower...

CHERRY HILL, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen food company, today announced the launch of their new cheesy burritos loaded with chunks of chicken breast and made with a proprietary low carb tortilla—available in the Club channel today, and coming to grocery stores in the coming months. Real Good Foods’ burritos are made us...

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Latin Metals Inc. (“Latin Metals” or the “Company”) - (TSXV: LMS)(OTCQB: LMSQF) a leading mineral exploration company in South America, announces that it has...

IFx-Hu2.0 demonstrated to have a promising safety profile at all 3 dose schedules tested

Renewable natural gas stored underground during Q4 2022 through Q2 2023 scheduled to begin generating revenues in June 2023; Positive cash flow from biogas expected in Q3 2023 CUPERTINO, CA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, announced today that its Aemetis Biogas subsidiary generated federal D3 Renewable Identification Numbers (D3 RI...

(Unless otherwise provided herein, all dollar amounts in this announcement are expressed in U.S. dollars.)

NEEDHAM, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients...

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (the “Company”), a global big data analytics software and services company, further to its release on May 30, 2023, is pleased...

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled -

- Trial includes high risk AML patients that have relapsed post allo-HSCT and are refractory to salvage therapy

ADELAIDE, Australia, June 05, 2023 (GLOBE NEWSWIRE) -- Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced the appointment of Michael S. Wyzga, M.B.A., and Remus Vezan M.D., Ph.D., to its...

Wenzhou, China, June 05, 2023 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer, designer, and exporter of high-quality products in the power supply...

Data show enhanced anti-tumor activity of AL102 over time

Interim data presented at ASCO show early evidence of single agent activity with meaningful reduction of several target lesionsBased on the favorable safety and tolerability data at all doses tested to date, the Company...

Data demonstrates the potential of ‘1805 to reset the immune system through its unique mechanism of action across various autoimmune diseases, including inflammatory bowel disease and rheumatoid arthritis

– Enrollment exceeded expectations, thus highlighting the large unmet need in non-obstructive hypertrophic cardiomyopathy –

Media Release

MONTREAL, June 05, 2023 (GLOBE NEWSWIRE) -- WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) is pleased to announce that it has completed the acquisition of Calibre Professional Services One Pty Ltd (“Calibre”),...

MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive...

The Phase 1/2 REVEAL trial is a first-in-human, randomized, dose-escalation and dose-expansion study evaluating the safety and preliminary efficacy of TSHA-102 in adults with Rett syndrome

100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two patients that received three doses remaining progression-free at 23.5 and 19.4 months, respectively.INB-200...

Phase I Clinical Trial in healthy subjects shows that NM3086 was safe and well tolerated at all doses (0.1 to 20 mg/kg) in six cohorts.Total AP inhibition was achieved through all cohorts and the duration of alternative...

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today...

Clinical activity observed in multiple tumor types; longer progression-free survival observed in patients with high target expression; ATRC-101 continues to be well-tolerated

PNC Joins Wells Fargo and JPMorgan in Lending Facility  ABL Credit Agreement maturity extended for 5 years to June 1, 2028

Industry expert joins as Triterras continues to scale its Supply Chain Finance & Working Capital Solutions

SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...

LYON, France and CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced the initiation...

- No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during the Phase 1a dose escalation portion of ongoing clinical study -

72% of Canadians believe Indigenous businesses are important to the creation of sustainable economic opportunity; only one-third claim to be unaware of Indigenous businesses as part of key findings of a Sodexo Survey

Newark, Delaware, June 05, 2023 (GLOBE NEWSWIRE) -- Mobiv Acquisition Corp (Nasdaq: MOBVU, MOBV, MOBVW) (the “Company”), a special purpose acquisition company, announced today that, on June 1, 2023, it notified the...

WOBURN, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies,...

This is the second deal announced between Rani and Celltrion, building upon a previously announced partnership for ustekinumab biosimilar for RT-111

AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools,...

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman Sachs 44th Annual...

DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors through the Program of...

CARMEL, Ind., June 05, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI)  invites you to attend its upcoming board education seminar. This free educational event will review important...

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific...

Virtual event to take place on June 14, 2023 at 1:00 pm ET

ASML reports transactions under its current share buyback program

Press Release

SYDNEY, Australia and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX: CHM) (“Chimeric Therapeutics”, “Chimeric” or the “Company”), a clinical-stage cell therapy company and an Australian leader in...

WINNIPEG, Manitoba, June 05, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that the Toronto Transit Commission (“TTC”) has awarded its subsidiary New Flyer Industries Canada ULC (“New Flyer”) a new five-year contract for 40-foot battery-electric buses. The total contract includes a firm order f...

LANCASTER, PA, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- EVERMIND Inc. (“EVERMIND”), a pioneering consumer products platform dedicated to cognitive health, has announced that it is evaluating a...

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of allogeneic, off-the-shelf,...

Partnership to boost Ethiopian telecom industry growth of cross-border transactions

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha Lithium” or the “Company”) today responded to the June 2, 2023 announcement...

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” or the “Company”), a Clean Technology Company accelerating the world’s transition to a...

SOUTH SAN FRANCISCO, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced that Aetna Wun Trombley, Ph.D., President and Chief Executive...

Broad-based collaboration with Max Planck and University Medical Center Gottingen yields attractive anti-IL-17 VHH antibodies (NanoAbs); includes exclusive worldwide license for all potential indications, beginning with...

SHANGHAI, China, June 05, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and...

VANCOUVER, BC, CANADA, June 05, 2023 (GLOBE NEWSWIRE) --

HESPERIA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (5E or the Company), a boron and lithium company with U.S. government Critical Infrastructure designation for its...

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Osisko Mining Inc. (TSX:OSK. “Osisko” or the “Corporation“) would like to provide the following update on the ongoing forest fire situation affecting the communities in Abitibi...

CUMBERLAND, Md., June 05, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of cannabinoids in the research, development, and commercialization of life changing medications,...

Patients treated with EFX for 12 weeks combined with GLP-1 achieved a 65% relative reduction in liver fat, compared to a 10% relative reduction for GLP-1 alone

- Plan to Initiate a Phase 1 Study of FHD-286 in Combination with Decitabine or Cytarabine in Relapsed and/or Refractory AML Patients in Q3’2023

Akoustis to Present at WSP Workshop, Industry Showcase, IMS Technical Session, and Interactive ForumBooth Demonstrations Include Wi-Fi 6E & 7, Medical, and Automotive Filter Solutions including BAW Filters, SAW...

-Results of the Brazilian field trials in corn plants cultivated with NFT were encouraging and confirmed the preliminary early-stage results in the greenhouse, showing greater efficiency in the use of nitrogen and water...

PITTSBURGH, June 05, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases,...

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that on June 1, 2023 the Bank of Montreal (“BMO”)...

CALGARY, Alberta, June 05, 2023 (GLOBE NEWSWIRE) -- Hammerhead Energy Inc. ("Hammerhead" or "HEI") (TSX: HHRS, HHRS.WT ; NASDAQ: HHRS, HHRSW) announces the results of its substantial issuer bid (the "Offer"), pursuant to...

Versatile solution helps to deter a wide range of security threats and performs operational tasks for consumer-facing businesses.

-- Achieved Primary Endpoint with Statistically Significant 45.8% Median Reduction in LDL-C (p < 0.0001) in patients treated with 10mg obicetrapib--

-LUMRYZ is the first and only once-at-bedtime oxybate for people living with narcolepsy

MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,...

Study aims to evaluate the safety and feasibility of RAG-17 in human patients and clinically validate Ractigen’s proprietary CNS delivery platform enabling new oligonucleotides therapeutics in the CNS

LONDON and SALT LAKE CITY, June 05, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) will report its third quarter fiscal year 2023 financial results on Friday, June 9, 2023, before market open. The...

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells...

NEW HAVEN, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that...

Arlington, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Arlington, Va. – Health experts from the American Institutes for Research (AIR) will present and share findings at AcademyHealth’s 2023 Annual Research Meeting (ARM),...

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that the Company’s Board of Directors has declared a quarterly dividend of US$0.025 per common...

JERSEY CITY, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTC:VENG) (“Vision Energy” or the “Company”) is pleased to announce it has concluded the pre-FEED study for all Phase 1 Green Ammonia...

HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the first...

SAINT-JÉRÔME, Quebec, June 05, 2023 (GLOBE NEWSWIRE) -- We are proud to announce that Bofu Agence Marketing recently obtained the CONCILIVI seal, which recognizes companies advocating better work-family balance for its...

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders,...

ANeuroTechreceives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

Josefine Roemmler-Zehrer, former Medical Director at Ipsen & Celgene, brings broad global clinical and medical affairs expertiseAdding further oncology experience to Immodulon’s leadership team as the company prepares...

Registrational study designed to support BLA submission of first-in-class biotherapeutic

BROOKFIELD, NEWS, June 05, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) announced that Bruce Flatt, Chief Executive Officer, is scheduled to deliver the keynote presentation at the...

GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of...

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) is pleased to announce the appointment of Anthea Bath as President and Chief Executive Officer effective July 1,...

TYSONS, Va., June 05, 2023 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE:PK) today announced that, starting in June, it ceased making payments toward the $725 million non-recourse...

ISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with “Sectoral Trends”, in a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual Circumstances

VILNIUS, Lithuania, June 05, 2023 (GLOBE NEWSWIRE) -- Digital health company Kilo Health has launched its newest product – habit tracking and lifestyle management app Greatness. The product is the latest edition in the...

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) ("Fusion Fuel"), an emerging leader in the green hydrogen sector, today announced financial results for the first quarter ended...

Pioneering startup introduces patented virtual keyboard and touch screen for enhanced mixed reality experiences

Vertex Founder and Industry Pioneer Joshua Boger, Ph.D. named as Executive Chairman of Alkeus

The Platform Serves the Department of Defense, Intelligence, and Federal Civilian Customers

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological...

Claims for catalytic converter thefts increased over 1,700% between 2018-2022

The study’s publication coincides with the famed economist’s 140th birthday.

Effective at the Open of Market Trading Today, the Company Began Trading as Btab Ecommerce Group, Inc. (OTC: BBTT)

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) is pleased to announce that commercial production has been achieved at the Juanicipio...

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) today announced several senior leadership changes to sharpen its strategic focus and seek to unlock long-term growth and...

SABUGO, Portugal, June 05, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green plc (NASDAQ: HTOO) is proud to announce the publication of its inaugural Environmental, Social and Governance (“ESG”) Report and the launch of its new...

Canadians are invited to create unique case designs for the Samsung Galaxy Z Flip4 at MURAL Festival in Montreal and the Samsung Experience Store in the CF Toronto Eaton Centre

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) regrets to report that a fatality involving a worker employed by a mining contractor occurred at the...

  One of the largest private investment rounds in European biotech to-dateNet proceeds will enhance ITM’s radiopharmaceutical pipeline, bolster commercial infrastructure, expand leading manufacturing capabilities, and enable strategic initiativesITM welcomes Temasek, BlackRock, QIA, Nextech, ATHOS and Carbyne as investorsGarching / Munich, June 5, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced an equity investmen...

WALL, N.J. and MADRID, Spain, June 05, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, and...

CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform, and CPI, the UK’s leading...

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Kiplin Metals Inc. (TSX-V: KIP) (the “Company” or “Kiplin”) has observed a significant increase in activity surrounding its Cluff Lake Road (CLR) uranium...

ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes

Did you lose money on investments in Cutera? If so, please visit Cutera, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Viatris? If so, please visit Viatris Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

Did you lose money on investments in Stem Inc.? If so, please visit Stem, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Beyond Meat? If so, please visit Beyond Meat Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Icahn Enterprises? If so, please visit Icahn Enterprises L.P. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Spirit AeroSystems? If so, please visit Spirit AeroSystems Holdings, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss...

Did you lose money on investments in adidas? If so, please visit adidas AG Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Telephone and Data Systems? If so, please visit Telephone and Data Systems, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

Did you lose money on investments in LivePerson? If so, please visit LivePerson, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to...

Did you lose money on investments in Allbirds? If so, please visit Allbirds, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Nutanix? If so, please visit Nutanix, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

Did you lose money on investments in Vertex Energy, Inc.? If so, please visit Vertex Energy, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.

BRADENTON, FL, June 05, 2023 (GLOBE NEWSWIRE) -- Alpha Transform Holdings, announced today that Wes Levitt, CFA will join the firm as Co-Chief Investment Officer.

MADRID, Spain, June 05, 2023 (GLOBE NEWSWIRE) -- Lleida.net (OTC.US) (ALLLN.PA) (LLN.MA) issued its 100 millionth certified email last week, a milestone in the company's history.

VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- VERSES AI Inc.  (CBOE CANADA:VERS) (OTCQX:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in the next generation of...

Oslo, Norway, June 05, 2023 (GLOBE NEWSWIRE) -- Leaders from the global shipping industry are taking action to align their businesses with what is needed to limit the worst impacts of climate change, according to those...

NEW YORK, NY, June 04, 2023 (GLOBE NEWSWIRE) -- YGG team is thrilled to announce that YGG SEA, the exclusive official guild partner of Yield Guild Games in Southeast Asia, has officially changed its name to W3GG,...

New CHM 1101 (CLXT CAR T) multi-center clinical trial activated at Sarah Cannon Research Institute (SCRI) in Austin, TexasEnrolment now open to patients with recurrent and/or progressive glioblastoma multiforme (GBM), the...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Relmada Therapeutics, Inc. (NYSE: RLMD), Bowlero...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RH (NYSE: RH), Alvotech (NASDAQ: ALVO), and...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Plug Power Inc....

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Beyond Meat Inc....

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Allbirds, Inc....

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against First Republic Bank...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Icahn Enterprises...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Medical Properties...

Summary:

Fort Collins, Colorado, June 04, 2023 (GLOBE NEWSWIRE) -- NEWS RELEASE FOR IMMEDIATE RELEASE June 1, 2023

Reference is made to the notice on 24 May 2023 regarding completion a private placement of 147.1 million shares at NOK 0.85 per share in IDEX Biometrics ASA. The placement was split in two tranches of 116.9 million shares...

Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily pretreated RANO-HGG evaluable patients

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary...

- Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microenvironment -

SAN FRANCISCO, June 04, 2023 (GLOBE NEWSWIRE) -- OKX, the second-largest crypto platform by trading volume and a leading Web3 technology company, has issued updates for the day of June 4, 2023.

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) --

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) --

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) --

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) --

The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and tolerabilityPositive clinical responses were reported in 8 out of 12 EVX-01 treated patientsHigh-quality neoantigens,...

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer, demonstrating that...

Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses with a well-tolerated safety profile; no progression in responding...

-  Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% overall response rate (ORR) in efficacy evaluable 2nd-line GIST patients;...

TORONTO, June 03, 2023 (GLOBE NEWSWIRE) -- Today, thousands of workers and community members gathered for rallies across the province as part of the Ontario Federation of Labour’s Enough Is Enough Day of Action....

– Met Primary Endpoint with 63.4% Median Reduction in LDL-C (p<0.0001) –

The airline understands the importance of environmental, social, and governance (ESG)